{"id":"https://genegraph.clinicalgenome.org/r/fa38807c-0eea-4988-85dd-0639d648a1aav1.1","type":"EvidenceStrengthAssertion","dc:description":["The *CLDN16* gene is located on chromosome 3 at 3q28. *CLDN16* encodes the renal tight junction protein claudin-16 which participates in the paracellular reabsorption of calcium and magnesium in the thick ascending limb of the loop of Henle (PMID: 18003771). \n\n*CLDN16* was first reported in relation to autosomal recessive renal hypomagnesemia, type 3 (OMIM: 248250) in 1999 (Simon et al., PMID: 10390358). The preferred disease name suggested for this disorder is 'autosomal recessive renal hypomagnesemia with hypercalciuria and nephrocalcinosis - *CLDN16*'. This progressive renal tubular disorder is characterized by excessive urinary losses of calcium and magnesium (PMID: 26613020). The mechanism of pathogenicity is known to be loss of function. \n\n13 variants (9 missense, 1 start-loss, 1 splice, 1 deletion and 1 nonsense) have been reported in nine probands in four publications (PMID: 10390358, 11518780, 18003771, 32869508) and are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. \nThis gene-disease relationship is also supported by expression, biochemical function, protein-protein interactions, and an animal model (PMID: 17442678, 10390358, 18188451). A total of 3.5/6 pts. for experimental evidence was reached\n\nIn summary, there is definitive evidence supporting the relationship between *CLDN16* and autosomal recessive renal hypomagnesemia, type 3 (OMIM: 248250). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Tubulopathy GCEP on the meeting date 12/06/2023 (SOP Version 9).","The *CLDN16* gene is located on chromosome 3 at 3q28. *CLDN16* encodes the renal tight junction protein claudin-16 which participates in the paracellular reabsorption of calcium and magnesium in the thick ascending limb of the loop of Henle (PMID: 18003771). \n\n*CLDN16* was first reported in relation to autosomal recessive renal hypomagnesemia, type 3 (OMIM: 248250) in 1999 (Simon et al., PMID: 10390358). The preferred disease name suggested for this disorder is 'autosomal recessive renal hypomagnesemia with hypercalciuria and nephrocalcinosis - *CLDN16*'. This progressive renal tubular disorder is characterized by excessive urinary losses of calcium and magnesium (PMID: 26613020). The mechanism of pathogenicity is known to be loss of function. \n\n13 variants (9 missense, 1 start-loss, 1 splice, 1 deletion and 1 nonsense) have been reported in nine probands in four publications (PMID: 10390358, 11518780, 18003771, 32869508) and are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. \nThis gene-disease relationship is also supported by expression, biochemical function, protein-protein interactions, and an animal model (PMID: 17442678, 10390358, 18188451). A total of 3.5/6 pts. for experimental evidence was reached\n\nIn summary, there is definitive evidence supporting the relationship between *CLDN16* and autosomal recessive renal hypomagnesemia, type 3 (OMIM: 248250). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/fa38807c-0eea-4988-85dd-0639d648a1aa","GCISnapshot":"https://genegraph.clinicalgenome.org/r/cd2b60d4-b932-4d0b-bc46-d6b0827a6333","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/cd2b60d4-b932-4d0b-bc46-d6b0827a6333_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10067","date":["2023-12-06T17:00:00.000Z","2023-12-06T05:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/cd2b60d4-b932-4d0b-bc46-d6b0827a6333_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10067","date":"2024-12-16T17:08:32.541Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd2b60d4-b932-4d0b-bc46-d6b0827a6333_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3bc33993-d45b-4c80-b129-eafef783fb76_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3bc33993-d45b-4c80-b129-eafef783fb76","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32869508","rdfs:label":"Garcia-Castano Proband","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c8170569-4064-4564-b27b-2fe0d5aadad2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.67G>A (p.Ala23Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355762677"}},"detectionMethod":"Exons and flanking intronic segments of CLDN16 and CLDN19 were analyzed by direct sequencing. A new assay was developed based on Quantitative Multiplex PCR of Short Fluorescent Fragments to investigate large CLDN16 deletions.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002917","obo:HP_0000103","obo:HP_0003158","obo:HP_0012622","obo:HP_0000121","obo:HP_0002150"],"secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/06be52f2-9663-43c7-bd08-7b68f0830567_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32869508","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8170569-4064-4564-b27b-2fe0d5aadad2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/06be52f2-9663-43c7-bd08-7b68f0830567","type":"EvidenceLine","dc:description":"Two variants in trans in this proband c.67G>A, p.A23T inherited maternally and a gross deletion lacking exons 4 and 5, c.(840+25_?)del inherited paternally. The deletion has been scored under the missense variant since the paper does not have the exact genomic coordinates of the deletion.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06be52f2-9663-43c7-bd08-7b68f0830567_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/749dcc68-d7ab-4de9-9719-c92d682cf45f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/749dcc68-d7ab-4de9-9719-c92d682cf45f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18003771","rdfs:label":"F77","allele":[{"id":"https://genegraph.clinicalgenome.org/r/cce463fb-ed06-4a32-8a5d-95fc8589228f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.53G>A (p.Gly18Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355762648"}},{"id":"https://genegraph.clinicalgenome.org/r/b61f50a3-1e56-4627-9ad5-947f2e054241","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.243G>T (p.Leu81Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117867"}}],"detectionMethod":"Single-strand conformation analysis and direct sequencing of CLDN16","firstTestingMethod":"SSCP","secondTestingMethod":"PCR","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0e53eaef-2399-4b0b-9a49-511188b2a190_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18003771","allele":{"id":"https://genegraph.clinicalgenome.org/r/cce463fb-ed06-4a32-8a5d-95fc8589228f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/bb383c6a-0783-4146-9436-8139b03d0a72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18003771","allele":{"id":"https://genegraph.clinicalgenome.org/r/b61f50a3-1e56-4627-9ad5-947f2e054241"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/bb383c6a-0783-4146-9436-8139b03d0a72","type":"EvidenceLine","dc:description":"Upgraded for being a founder variant (PMID: 11518780)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb383c6a-0783-4146-9436-8139b03d0a72_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bb383c6a-0783-4146-9436-8139b03d0a72_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Electrophysiological study measuring the permeability of sodium and calcium demonstrated partial loss of function with this variant (PMID: 16234325).\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0e53eaef-2399-4b0b-9a49-511188b2a190","type":"EvidenceLine","dc:description":"Electrophysiological study measuring the permeability of sodium and calcium demonstrated complete loss of function with this variant.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e53eaef-2399-4b0b-9a49-511188b2a190_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0e53eaef-2399-4b0b-9a49-511188b2a190_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"CL calculated for G88E\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e7c8df7a-1c55-4763-bdd1-7010cb965bf1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7c8df7a-1c55-4763-bdd1-7010cb965bf1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18003771","rdfs:label":"F80-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b9bdb23-bde8-4234-aa93-1ce604a5172b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.2T>C (p.Met1Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355762540"}},"detectionMethod":"Single-strand conformation analysis and direct sequencing of CLDN16","firstTestingMethod":"SSCP","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1908f1a3-9419-4ec9-92b2-01b473cfde54_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18003771","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b9bdb23-bde8-4234-aa93-1ce604a5172b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/1908f1a3-9419-4ec9-92b2-01b473cfde54","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1908f1a3-9419-4ec9-92b2-01b473cfde54_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1908f1a3-9419-4ec9-92b2-01b473cfde54_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The M71T variant is localized to the lysosome.\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/86ce7c21-1b1d-4bfb-88d6-5e761834a58c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86ce7c21-1b1d-4bfb-88d6-5e761834a58c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11518780","rdfs:label":"F15 ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5ee038b3-6567-436d-95bb-b6e4e8bb555f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.236G>T (p.Arg79Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355765992"}},"detectionMethod":"Single-strand conformation polymorphism was performed to identify CLDN16 variants and then variants confirmed with direct sequencing ","firstTestingMethod":"SSCP","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/85536148-1d64-4650-afa2-c04ca912c3b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11518780","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ee038b3-6567-436d-95bb-b6e4e8bb555f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/85536148-1d64-4650-afa2-c04ca912c3b3","type":"EvidenceLine","dc:description":"Total score should be 0.6 for the homozygous missense variant with functional evidence.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85536148-1d64-4650-afa2-c04ca912c3b3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/85536148-1d64-4650-afa2-c04ca912c3b3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant localizes to the endoplasmic reticulum, and fails to colocalize with CLDN19 (PMID: 18188451).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b74d781d-8e3f-4f0b-88f6-4b858bfdbe1a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b74d781d-8e3f-4f0b-88f6-4b858bfdbe1a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","rdfs:label":"K118-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8999229-64ca-4475-ba22-809fec66ea2a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.505G>A (p.Gly169Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117859"}},"detectionMethod":"Genotyped polymorphic loci across the human genome and analyzed linkage to the trait. Followed by exon trapping and single-strand conformation polymorphism to identify CLDN16 variants in the affected families\n","firstTestingMethod":"Linkage analysis","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/fe90716f-514e-425f-9aa2-828d2a04d04b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8999229-64ca-4475-ba22-809fec66ea2a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/fe90716f-514e-425f-9aa2-828d2a04d04b","type":"EvidenceLine","dc:description":"Total score should be 0.6 for the homozygous missense variant with functional evidence.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe90716f-514e-425f-9aa2-828d2a04d04b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/fe90716f-514e-425f-9aa2-828d2a04d04b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant caused mislocalization to the golgi apparatus rather than the tight junction (PMID: 16234325).\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a4cadfd1-f010-4b69-9e31-c91927e6f617_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4cadfd1-f010-4b69-9e31-c91927e6f617","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","rdfs:label":"K106-1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/bde8d3e6-c726-4bff-8f1f-17a4344ff1fd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.494C>T (p.Ser165Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117866"}},{"id":"https://genegraph.clinicalgenome.org/r/ae062367-8fc9-4a9d-906c-d49f9e4184c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.383G>A (p.Gly128Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117861"}}],"detectionMethod":"Genotyped polymorphic loci across the human genome and analyzed linkage to the trait. Followed by exon trapping and single-strand conformation polymorphism to identify CLDN16 variants in the affected families\n","firstTestingMethod":"Linkage analysis","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/76ea929e-07eb-42ae-98a3-c17cc9a07184_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","allele":{"id":"https://genegraph.clinicalgenome.org/r/bde8d3e6-c726-4bff-8f1f-17a4344ff1fd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/b9f863ff-3502-4eea-be0a-216f4ffc56b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","allele":{"id":"https://genegraph.clinicalgenome.org/r/ae062367-8fc9-4a9d-906c-d49f9e4184c7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b9f863ff-3502-4eea-be0a-216f4ffc56b1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9f863ff-3502-4eea-be0a-216f4ffc56b1_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b9f863ff-3502-4eea-be0a-216f4ffc56b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Electrophysiological study measuring the permeability of sodium and calcium demonstrated complete loss of function with this variant (PMID: 16234325).\n\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/76ea929e-07eb-42ae-98a3-c17cc9a07184","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76ea929e-07eb-42ae-98a3-c17cc9a07184_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/2d783111-0783-4722-b93f-b3fa5c9f7001_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d783111-0783-4722-b93f-b3fa5c9f7001","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","rdfs:label":"K112-1 ","allele":{"id":"https://genegraph.clinicalgenome.org/r/62aa98d0-8018-4143-9b5b-8a951f8b516b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.361G>A (p.Gly121Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117860"}},"detectionMethod":"Genotyped polymorphic loci across the human genome and analyzed linkage to the trait. Followed by exon trapping and single-strand conformation polymorphism to identify CLDN16 variants in the affected families","firstTestingMethod":"Linkage analysis","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5090f786-2943-4f90-93fd-7c64c6ab0b32_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","allele":{"id":"https://genegraph.clinicalgenome.org/r/62aa98d0-8018-4143-9b5b-8a951f8b516b"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/5090f786-2943-4f90-93fd-7c64c6ab0b32","type":"EvidenceLine","dc:description":"Total score should be 0.6 for the homozygous missense variant with functional evidence.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5090f786-2943-4f90-93fd-7c64c6ab0b32_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5090f786-2943-4f90-93fd-7c64c6ab0b32_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Electrophysiological study measuring the permeability of sodium and calcium demonstrated partial loss of function with this variant (PMID: 16234325).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f918a5c4-18bc-4cfd-82b0-f33c10da5425_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f918a5c4-18bc-4cfd-82b0-f33c10da5425","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18003771","rdfs:label":"F63-1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/730931a3-660a-41f3-a8d8-3c08758b0272","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.574+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355767544"}},{"id":"https://genegraph.clinicalgenome.org/r/f77a32d0-4487-41d6-a237-2a4193324090","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.436C>T (p.Arg146Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2753874"}}],"detectionMethod":"Single-strand conformation analysis and direct sequencing of CLDN16","firstTestingMethod":"SSCP","secondTestingMethod":"PCR","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/3f417596-bfb3-48b4-a82f-8312a048b1ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18003771","allele":{"id":"https://genegraph.clinicalgenome.org/r/f77a32d0-4487-41d6-a237-2a4193324090"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/80ef2b58-0eed-469f-89a5-2c42099093b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18003771","allele":{"id":"https://genegraph.clinicalgenome.org/r/730931a3-660a-41f3-a8d8-3c08758b0272"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/3f417596-bfb3-48b4-a82f-8312a048b1ee","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f417596-bfb3-48b4-a82f-8312a048b1ee_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3f417596-bfb3-48b4-a82f-8312a048b1ee_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The functional consequences of  CLDN16 mutations were analyzed after heterologous expression in MDCK and LLC-PK1 cells. The authors observed a significant decrease of the dilution potential and the ratio of permeability of Na+ over Clâˆ’","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/80ef2b58-0eed-469f-89a5-2c42099093b3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80ef2b58-0eed-469f-89a5-2c42099093b3_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/879d17bd-e20c-40d5-a2c2-5b74e73f38f7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/879d17bd-e20c-40d5-a2c2-5b74e73f38f7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","rdfs:label":"K114-1  ","allele":{"id":"https://genegraph.clinicalgenome.org/r/b51df4cf-1989-4b70-8ff9-234457b976c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006580.4(CLDN16):c.235C>T (p.Arg79Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117857"}},"detectionMethod":"Genotyped polymorphic loci across the human genome and analyzed linkage to the trait. Followed by exon trapping and single-strand conformation polymorphism to identify CLDN16 variants in the affected families\n","firstTestingMethod":"Linkage analysis","secondTestingMethod":"SSCP","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/aaf5837e-a39d-47d4-9ae4-72fddbb64ddf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","allele":{"id":"https://genegraph.clinicalgenome.org/r/b51df4cf-1989-4b70-8ff9-234457b976c8"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/aaf5837e-a39d-47d4-9ae4-72fddbb64ddf","type":"EvidenceLine","dc:description":"Downgrading for homozygosity and consanguinity","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aaf5837e-a39d-47d4-9ae4-72fddbb64ddf_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/cd2b60d4-b932-4d0b-bc46-d6b0827a6333_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd2b60d4-b932-4d0b-bc46-d6b0827a6333_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7038b325-9637-4d3d-9628-cb43becf93a9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c3ad034-f2b8-491a-a724-9e50e2e3a02a","type":"Finding","dc:description":"Northern (RNA) blots revealed that CLDN16 is expressed as a 3.5-kb transcript that is found only in kidney and specifically in the thick ascending limb and distal convoluted tubule.\nAdditionally, immunolocalization of CLDN16 was demonstrated at intercellular junctions of a subset of renal tubules, including all tubule segments staining for the TAL-specific Tamm-Horsfall protein\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10390358","rdfs:label":"Northern blot and immunolocalization","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0f25d593-1810-46f0-8e38-81c257910d55","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b5873ef-165d-4b4a-89b7-dec44bb25753","type":"Finding","dc:description":"Coimmunoprecipitation of CLDN16 and CLDN19 was identified in cotransfected HEK293 cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18188451","rdfs:label":"Claudin-16 and claudin-19 interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bbe579c1-24bd-4b81-a501-4be678ddcfe2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02db9174-15aa-43a3-9699-71bf1d12f8ca","type":"Finding","dc:description":"Demonstrates that this protein is involved in the transfer of magnesium. Therefore it is in keeping that mutations to this gene would cause the phenotype of hypomagnesemia in patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18188451","rdfs:label":"Cation permeability","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cd2b60d4-b932-4d0b-bc46-d6b0827a6333_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10ad2399-85d2-43bf-bebe-ab63621eaa9b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d3fefe5-ce9a-443e-bcd5-4d49dcb77b09","type":"Finding","dc:description":"Strong mouse model mimicking many of the phenotypes associated with the disease in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17442678","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Definitive","sequence":9553,"specifiedBy":"GeneValidityCriteria9","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/FKQxi75Je9o","type":"GeneValidityProposition","disease":"obo:MONDO_0009550","gene":"hgnc:2037","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_cd2b60d4-b932-4d0b-bc46-d6b0827a6333-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}